Skip to main content
Tech.euFundingExplorerBeta

Univercells

Designs bio-process solutions for healthcare providers

Univercells has raised €62M across 4 funding rounds from 10 investors, most recently a round in Oct 2022. Based in Brussels, Belgium; founded 2013; active in Healthtech. Data as of 28 Oct 2026.

Brussels, BelgiumFounded 2013univercells.com ↗
Total raised
€62M
€61,800,000
Funding rounds
4
Investors
10
distinct backers
Active since
2015-10
latest 2022-10

Funding by year

EUR raised per year
Univercells — funding by year — interactive chart.
Data table
Univercells — funding by year
2015€3.0M
2016€12M
2017€3.0M
2022€44M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 4 rounds raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2022-10-19Other€44M3D,Adjuvant Capital,Christian Dumolin,Hubert Bonnet,Jean-Marc Heynderickx,Olivier van der Rest+2 moreView deal →
2017-04-01Other€3.0MTakeda VenturesView deal →
2016-12-01Grant€12MGates FoundationView deal →
2015-10-01Early VC€3.0MTakeda VenturesView deal →

Similar companies

same sector or country

Global coverage: FundingData